Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | taurine | 12 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 207 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | taurine | 237 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | taurine | 260 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 260 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | taurine | 300 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | taurine | 304 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | taurine | 328 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 349 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | taurine | 382 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | taurine | 386 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
GC POSITIVE ION MODE | taurine | 445 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | taurine | 578 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | taurine | 590 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 596 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
GC POSITIVE ION MODE | taurine | 660 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | taurine | 675 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | taurine | 678 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | taurine | 775 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | taurine | 819 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | taurine | 843 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | taurine | 853 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | taurine | 867 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | taurine | 942 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 943 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | taurine | 1054 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 1104 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 1207 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
GC POSITIVE ION MODE | taurine | 1302 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | taurine | 1461 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 1567 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | taurine | 1845 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
GC POSITIVE ION MODE | taurine | 1867 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
GC POSITIVE ION MODE | taurine | 2065 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 2086 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 2149 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 2166 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 2243 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 2290 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 2349 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | taurine | 2425 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | taurine | 2567 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | taurine | 2645 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 2664 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | taurine | 2758 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 2780 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | taurine | 2852 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 2967 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 2998 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 3026 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 3104 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 3204 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
GC POSITIVE ION MODE | taurine | 3799 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 4157 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | taurine | 4657 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | taurine | 4668 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | taurine | 5222 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | taurine | 7530 | Counts | NA | NA | NA | - |